The credibility of Hb A1c as a gold standard for the measurement of control of diabetes in TM patients has been questioned because the hemoglobin composition of patients’ erythrocytes is considerably modified, due to regular and frequent transfusions. This evidence concerns the gene GSTM1 and diabetes mellitus.